Profile of protein expression of the colon cancer cell line SW480 with survivin/shRNA

European Journal of Cancer Prevention

Volumn 20, Issue 3, 2011, Pages 190-198

  Wang, Xuehu ^a   Fu, Zhongxue ^a   Zhao, Yu ^a   Wu, Xingye ^a   Shen, Wei ^a  

^a THE FIRST AFFILIATED HOSPITAL OF CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

apoptosis; colon cancer; mitosis; proteomics; RNA interference; survivin

Indexed keywords

SHORT HAIRPIN RNA; SURVIVIN;

ARTICLE; CANCER CELL CULTURE; COLON CANCER; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEOMICS;

ADENOVIRIDAE; APOPTOSIS; BLOTTING, WESTERN; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; NEOPLASM PROTEINS; PROTEOMICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TWO-DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS;

EID: 79955069610     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e3283431c08     Document Type: Article

References (31)

1. Altieri DC (2003). Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22:8581-8589. (Pubitemid 38019195)
2. Altieri DC (2008). Survivin, cancer networks and pathway-directed drug discovery. Nat Rev Cancer 8:61-70.
3. Carelli S, Lesma E, Paratore S, Grande V, Zadra G, Bosari S, et al. (2007). Survivin expression in tuberous sclerosis complex cells. Mol Med 13:166-177. (Pubitemid 46944959)
4. Cecconi D, Donadelli M, Rinalducci S, Zolla L, Scupoli MT, Scarpa A, et al. (2007). Proteomic analysis of pancreatic endocrine tumor cell lines treated with the histone deacetylase inhibitor trichostatin A. Proteomics 7:1644-1653. (Pubitemid 46841825)
5. De Falco G, Bellan C, D'Amuri A, Angeloni G, Leucci E, Giordano A, et al. (2005). CDK9 regulates neural differentiation and its expression correlates with the differentiation grade of neuroblastoma and PNET tumors. Cancer Biol Ther 4:277-281. (Pubitemid 41351286)
6. Fichou Y, Ferec C (2006). The potential of oligonucleotides for therapeutic applications. Trends Biotechnol 24:563-570. (Pubitemid 44751217)
7. Fields AC, Cotsonis G, Sexton D, Santoianni R, Cohen C (2004). Survivin expression in hepatocellular carcinoma: correlation with proliferation, prognostic parameters, and outcome. Mod Pathol 17:1378-1385. (Pubitemid 39472993)
8. Garriga J, Bhattacharya S, Calbo J, Marshall RM, Truongcao M, Haines DS, et al. (2003). CDK9 is constitutively expressed throughout the cell cycle, and its steady-state expression is independent of SKP2. Mol Cell Biol 23: 5165-5173. (Pubitemid 36950872)
9. Gordon GJ, Mani M, Mukhopadhyay L, Dong L, Yeap BY, Sugarbaker DJ, et al. (2007). Inhibitor of apoptosis proteins is regulated by tumour necrosis factora in malignant pleural mesothelioma. J Pathol 211:439-446. (Pubitemid 46332555)
10. Hibberts NA, Simpson DJ, Bicknell JE, Broome JC, Hoban PR, Clayton RN, et al. (1999). Analysis of cyclin D1 (CCND1) allelic imbalance and overexpression in sporadic human pituitary tumors. Clin Cancer Res 5:2133-2139. (Pubitemid 29399269)
11. Kennedy SM, O'Driscoll L, Purcell R, Fitz-Simons N, McDermott EW, Hill AD, et al. (2003). Prognostic importance of survivin in breast cancer. Br J Cancer 88:1077-1083. (Pubitemid 36560779)
12. Krantic S, Mechawar N, Reix S, Quirion R (2007). Apoptosis-inducing factor: a matter of neuron life and death. Prog Neurobiol 81:179-196. (Pubitemid 46282274)
13. Li F, Yang J, Ramnath N, Javle MM, Tan D (2005). Nuclear or cytoplasmic expression of survivin: what is the significance? Int J Cancer 114:509-512. (Pubitemid 40349608)
14. Liang X, Da M, Zhuang Z, Wu W, Wu Z, Wu Y, et al. (2009). Effects of survivin on cell proliferation and apoptosis in MG-63 cells in vitro. Cell Biol Int 33:119-124.
15. Lin LJ, Zheng CQ, Jin Y, Ma Y, Jiang WG, Ma T (2003). Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenterol 9:974-977. (Pubitemid 36681663)
16. Milli A, Cecconi D, Campostrini N, Timperio AM, Zolla L, Righetti SC, et al. (2008). A proteomic approach for evaluating the cell response to a novel histone deacetylase inhibitor in colon cancer cells. Biochim Biophys Acta 1784:1702-1710.
17. Mita AC, Mita MM, Nawrocki ST, Giles FJ (2008). Survivin: key regulator of mitosis and apoptosis and novel target for cancer therapeutics. Clin Cancer Res 14:5000-5005.
18. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, et al. (2000a). Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci U S A 97:13103-13107.
19. O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, Li F, et al. (2000b). Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156:393-398. (Pubitemid 30643793)
20. O'Driscoll L, Linehan R, S MK, Cronin D, Purcell R, Glynn S, et al. (2003). Lack of prognostic significance of survivin, survivin-δEx3, survivin-2B, galectin-3, bag-1, BAX-α and MRP-1 mRNAs in breast cancer. Cancer Lett 201:225-236. (Pubitemid 37357172)
21. Payne SR, Kemp CJ (2003). p27(Kip1; CDKN1b)-deficient mice are susceptible to chemical carcinogenesis and may be a useful model for carcinogen screening. Toxicol Pathol 31:355-363. (Pubitemid 36897231)
22. Shi Y (2002). Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell 9:459-470. (Pubitemid 34273778)
23. Shin S, Sung BJ, Cho YS, Kim HJ, Ha NC, Hwang JI, et al. (2001). An antiapoptotic protein human survivin is a direct inhibitor of caspase-3 and -7. Biochemistry 40:1117-1123. (Pubitemid 32108606)
24. Song H, Xin XY, Xiao F, Wang DT, Yue QH, Han X (2008). Survivin gene RNA interference inhibits proliferation, induces apoptosis, and enhances radiosensitivity in HeLa cells. Eur J Obstet Gynecol Reprod Biol 136:83-89.
25. Span PN, Sweep FC,Wiegerinck ET, Tjan-Heijnen VC, Manders P, Beex LV, et al. (2004). Survivin is an independent prognostic marker for risk stratification of breast cancer patients. Clin Chem 50:1986-1993. (Pubitemid 39425834)
26. Takai N, Miyazaki T, Nishida M, Nasu K, Miyakawa I (2002). Survivin expression correlates with clinical stage, histological grade, invasive behavior and survival rate in endometrial carcinoma. Cancer Lett 184:105-116. (Pubitemid 34718112)
27. Velculescu VE, Madden SL, Zhang L, Lash AE, Yu J, Rago C, et al. (1999). Analysis of human transcriptomes. Nat Genet 23:387-388.
28. Wang CY, Fu ZX (2007). Effect of RNAi-mediated survivin gene with conditionally replicating adenovirus silencing on propagation and apoptosis of colon carcinoma cell lines HT-29. Chin J Exp Surg 24:563-567.
29. Wang J, Chun HJ,Wong W, Spencer DM, Lenardo MJ (2001). Caspase-10 is an initiator of caspase in death receptor signaling. Proc Natl Acad Sci U S A 98:13884-13888. (Pubitemid 33115993)
30. Wang YF, Wang YF, Bing PX, Zhu Y (2008). Relationship between the expressions of survivin, capase-8 and cell apoptosis in osteosarcoma. Journal of China Medical University 1:73-75.
31. Yamashita S, Masuda Y, Kurizaki T, Haga Y, Murayama T, Ikei S, et al. (2007). Survivin expression predicts early recurrence in early-stage breast cancer. Anticancer Res 27:2803-2808. (Pubitemid 47228001)